TUESDAY, Dec. 20 (HealthDay News) -- Edarbyclor (azilsartan medoxomil and chlorthalidone) has been approved by the U.S. Food and Drug Administration to treat high blood pressure in adults, maker Takeda Pharmaceutical Co. Ltd. said Tuesday in a news release.
Latest High Blood Pressure News
The drug combines Edarbi, an angiotensin II receptor blocker, with the diuretic chlorthalidone. The former blocks the actions of a natural hormone, allowing blood vessels to stay relaxed and open. Diuretics increase the flow of urine from the body, which helps lower blood pressure.
High blood pressure affects about 75 million Americans, or nearly one in three adults, the Japanese drug maker said. This includes more than half of people aged 60 and older.
-- Scott Roberts
Copyright © 2011 HealthDay. All rights reserved.
Subscribe to MedicineNet's General Health Newsletter